Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine

Kidney International

Volumn 85, Issue 5, 2014, Pages 1225-1237

  Hogan, Marie C ^a   Johnson, Kenneth L ^b   Zenka, Roman M ^b   Cristine Charlesworth, M ^b   Madden, Benjamin J ^b   Mahoney, Doug W ^a   Oberg, Ann L ^a   Huang, Bing Q ^a   Leontovich, Alexey A ^a   Nesbitt, Lisa L ^a   Bakeberg, Jason L ^a   McCormick, Daniel J ^b   Robert Bergen, H ^b   Ward, Christopher J ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Actin cytoskeleton; Exosome; Glomerular disease; Podocyte; Proteomics; Q exactive mass spectrometer

Indexed keywords

ALBUMIN; COMPLEMENT; INTEGRIN; NEPHRIN; PHOSPHOLIPASE A2 RECEPTOR; PODOCALYXIN; PODOCIN; PROTEINASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; BIOLOGICAL MARKER;

ACTIN FILAMENT; ADOLESCENT; ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; EXOSOME; FEMALE; FRACTIONATION; GENETIC DISORDER; GLOMERULAR MEMBRANOUS VESICLE; GLOMERULOPATHY; GLOMERULUS; HUMAN; MALE; MEMBRANE VESICLE; PODOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SIGNAL TRANSDUCTION; TRANSMISSION ELECTRON MICROSCOPY; URINE; WESTERN BLOTTING; AMINO ACID SEQUENCE; CASE CONTROL STUDY; CHEMISTRY; GLOMERULUS BASEMENT MEMBRANE; KIDNEY DISEASES; MOLECULAR GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCEDURES; PROTEINURIA; URINALYSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CENTRIFUGATION, DENSITY GRADIENT; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXOSOMES; FEMALE; GLOMERULAR BASEMENT MEMBRANE; HUMANS; KIDNEY DISEASES; MALE; MOLECULAR SEQUENCE DATA; PODOCYTES; PROTEINURIA; PROTEOMICS; URINALYSIS; URINE; YOUNG ADULT;

EID: 84899954902     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.422     Document Type: Article

References (96)

1. Keller S, Sanderson MP, Stoeck A et al. Exosomes: from biogenesis and secretion to biological function. Immunol Lett 2006; 107: 102-108.
2. Johnstone RM, Adam M, Hammond JR et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 1987; 262: 9412-9420.
3. Johnstone RM. Revisiting the road to the discovery of exosomes. Blood Cells Molecules Diseases 2005; 34: 214-219.
4. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004; 101: 13368-13373.
5. Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics 2006; 5: 1760-1771.
6. Knepper MA, Pisitkun T. Exosomes in urine: who would have thought.? Kidney Int 2007; 72: 1043-1045.
7. Bayer ME. An electron microscope examination of urinary mucoprotein and its interaction with influenza virus. J Cell Biol 1964; 21: 265-274.
8. Fernandez-Llama P, Khositseth S, Gonzales PA et al. Tamm-Horsfall protein and urinary exosome isolation. Kidney Int 77: 736-742.
9. Hiemstra TF, Charles PD, Hester SS et al. Uromodulin exclusion list improves urinary exosomal protein identification. J Biomol Tech 2011; 22: 136-145.
10. Hogan MC, Manganelli L, Woollard JR et al. Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol 2009; 20: 278-288.
11. Arac D, Boucard AA, Bolliger MF et al. A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis. EMBO J 2012; 31: 1364-1378.
12. Bakeberg JL, Tammachote R, Woollard JR et al. Epitope-tagged Pkhd1 tracks the processing, secretion, and localization of fibrocystin. J Am Soc Nephrol 2011; 22: 2266-2277.
13. Gonzales PA, Pisitkun T, Hoffert JD et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol 2009; 20: 363-379.
14. Zhou H, Yuen PS, Pisitkun T et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 2006; 69: 1471-1476.
15. Wang Z, Hill S, Luther JM et al. Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT). Proteomics 2012; 12: 329-338.
16. Raj DAA, Fiume I, Capasso G et al. A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes. Kidney Int 2012; 81: 1263-1272.
17. Kershaw DB, Beck SG, Wharram BL et al. Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin. J Biol Chem 1997; 272: 15708-15714.
18. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002; 13: 3005-3015.
19. Miyamoto M, Yoshida Y, Taguchi I et al. In-depth proteomic profiling of the normal human kidney glomerulus using two-dimensional protein prefractionation in combination with liquid chromatography-tandem mass spectrometry. J Proteome Res 2007; 6: 3680-3690.
20. Hogan M. In-Depth Proteomic Analysis of Podocin-Rich Exosomes in Human Urine. JASN: Denver, CO, USA, 2010 pp F-PO1996.
21. Neubert H, Bonnert TP, Rumpel K et al. Label-free detection of differential protein expression by LC/MALDI mass spectrometry. J Proteome Res 2008; 7: 2270-2279.
22. Wiener MC, Sachs JR, Deyanova EG et al. Differential mass spectrometry: a label-free LC-MS method for finding significant differences in complex peptide and protein mixtures. Anal Chem 2004; 76: 6085-6096.
23. Manenti L, Vaglio A, Buzio C. New aspects of membranoproliferative glomerulonephritis. N Engl J Med 2012; 367: 86-87.
24. Vitureira N, Andrés R, Pérez-Mart?́nez E et al. Podocalyxin is a novel polysialylated neural adhesion protein with multiple roles in neural development and synapse formation. PloS One 2010; 5: e12003.
25. Douglas LuW, Funkelstein L, Toneff T et al. Cathepsin H functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin peptide neurotransmitters. J Neurochem 2012; 122: 512-522.
26. Hu N, Westra J, Kallenberg CG. Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's granulomatosis. Autoimmun Rev 2009; 8: 510-514.
27. Michalski A, Damoc E, Hauschild JP et al. Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol Cell Proteomics 2011; 10: M111 011015.
28. Hara M, Yanagihara T, Kihara I et al. Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. J Am Soc Nephrol 2005; 16: 408-416.
29. Hara M, Yanagihara T, Hirayama Y et al. Podocyte membrane vesicles in urine originate from tip vesiculation of podocyte microvilli. Hum Pathol 2010; 41: 1265-1275.
30. Fernandez D, Larrucea S, Nowakowski A et al. Release of podocalyxin into the extracellular space Role of metalloproteinases. Biochim Biophys Acta 2011; 1813: 1504-1510.
31. Musante L, Saraswat M, Duriez E et al. Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. PloS One 2012; 7: e37279.
32. Ruotsalainen V, Ljungberg P, Wartiovaara J et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 1999; 96: 7962-7967.
33. Winn MP, Conlon PJ, Lynn KL et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308: 1801-1804.
34. Reiser J, Polu KR, Moller CC et al. TRPC6 is a glomerular slit diaphragmassociated channel required for normal renal function. Nat Genet 2005; 37: 739-744.
35. Beck LH, Bonegio RGB, Lambeau G et al. M-type phospholipase A1 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21.
36. Zhou H, Cheruvanky A, Hu X et al. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 2008; 74: 613-621.
37. Hill GS, Karoui KE, Karras A et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies. Kidney Int 2011; 79: 635-642.
38. Dewald B, Rindlerludwig R, Bretz U et al. Subcellular-localization and heterogeneity of neutral proteases in neutrophilic polymorphonuclear leukocytes. J Exp Med 1975; 141: 709-723.
39. Csernok E, Ludemann J, Gross WL et al. Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am J Pathol 1990; 137: 1113-1120.
40. Gupta S, Niles J, McCluskey R et al. Identity of Wegener's autoantigen (p29) with proteinase 3 and myeloblastin [letter]. Blood 1990; 76: 2162.
41. Gabay JE, Scott RW, Campanelli D et al. Antibiotic proteins of human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 1989; 86: 5610-5614.
42. Campanelli D, Melchior M, Fu Y et al. Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med 1990; 172: 1709-1715.
43. Rood IM, Deegens JKJ, Merchant ML et al. Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int 2010; 78: 810-816.
44. Cheruvanky A, Zhou H, Pisitkun T et al. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am J Physiol Renal Physiol 2007; 292: F1657-F1661.
45. Assmann KJ, Koene RA, Wetzels JF. Familial glomerulonephritis characterized by massive deposits of fibronectin. Am J Kidney Dis 1995; 25: 781-791.
46. Strom EH, Banfi G, Krapf R et al. Glomerulopathy associated with predominant fibronectin deposits: a newly recognized hereditary disease. Kidney Int 1995; 48: 163-170.
47. Kantarci S, Al-Gazali L, Hill RS et al. Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculoacoustico- renal syndromes. Nat Genet 2007; 39: 957-959.
48. Kerjaschki D, Farquhar MG. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 1983; 157: 667-686.
49. Storm T, Emma F, Verroust PJ et al. A patient with cubilin deficiency. N Engl J Med 2011; 364: 89-91.
50. Ovunc B, Ashraf S, Vega-Warner V et al. Mutation analysis of NPHS1 in a worldwide cohort of congenital nephrotic syndrome patients. Nephron Clin Pract 2012; 120: c139-c146.
51. Fremeaux-Bacchi V, Miller EC, Liszewski MK et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 2008; 112: 4948-4952.
52. Geerdink L, Westra D, van Wijk J et al. Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics. Pediatr Nephrol 2012; 27: 1283-1291.
53. Fremeaux-Bacchi V, Dragon-Durey MA, Blouin J et al. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. J Med Genet 2004; 41: e84.
54. Heath KE, Campos-Barros A, Toren A et al. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001; 69: 1033-1045.
55. Johnstone DB, Zhang J, George B et al. Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2 a predisposes mice to glomerulopathy. Mol Cell Biol 2011; 31: 2162-2170.
56. Ozaltin F, Ibsirlioglu T, Taskiran Ekim Z et al. Disruption of PTPRO causes childhood-onset nephrotic syndrome. Am J Hum Genet 2011; 89: 139-147.
57. Tawadrous H, Maga T, Sharma J et al. A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic. syndrome. Pediatr Nephrol 2010; 25: 947-951.
58. Shih NY, Li J, Karpitskii V et al. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999; 286: 312-315.
59. Kim JM, Wu H, Green G et al. CD2-Associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003; 300: 1298-1300.
60. Abe K, Miyazaki M, Koji T et al. Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney. Kidney Int 1998; 54: 120-130.
61. Shibata T, Cosio FG, Birmingham DJ. Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol 1991; 147: 3901-3908.
62. Ben-Smith A, Dove SK, Martin A et al. Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcg receptor ligation. Blood 2001; 98: 1448-1455.
63. Relle M, Cash H, Brochhausen C et al. New perspectives on the renal slit diaphragm protein podocin. Mod Pathol 2011; 24: 1101-1110.
64. Jenis EH, Lowenthal DT. Introduction. In: Jenis, Lowenthal (eds.), Kidney Biopsy Interpretation. FA Davis: Philadelphia, PA, 1977.
65. Karamatic Crew V, Burton N, Kagan A et al. CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 2004; 104: 2217-2223.
66. Sachs N, Kreft M, van den Bergh Weerman MA et al. Kidney failure in mice lacking the tetraspanin CD151. J Cell Biol 2006; 175: 33-39.
67. Yoo SH, Lee K, Chae JY et al. CD151 expression can predict cancer progression in clear cell renal cell carcinoma. Histopathology 2011; 58: 191-197.
68. Roselli S, Baleato RM, Guthrie PL et al. Deletion of Cd151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane. Am J Pathol 2008; 173: 927-937.
69. Sachs N, Claessen N, Aten J et al. Blood pressure influences end-stage renal disease of Cd151 knockout mice. J Clin Investig 2012; 122: 348-358.
70. Has C, Sparta G, Kiritsi D et al. Integrin a3 mutations with kidney, lung, and skin disease. N Engl J Med 2012; 366: 1508-1514.
71. Nicolaou N, Margadant C, Kevelam SH et al. Gain of glycosylation in integrin a3 causes lung disease and nephrotic syndrome. J Clin Investig 2012 0 122: 4375-4387.
72. Gupta IR, Baldwin C, Auguste D et al. ARHGDIA: a novel gene implicated in nephrotic syndrome. J Med Genet 2013; 50: 330-338.
73. Gee HY, Saisawat P, Ashraf S et al. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Investig 2013; 123: 3243-3253.
74. Groffen AJA, Buskens CAF, van Kuppevelt TH et al. Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur J Biochem 1998; 254: 123-128.
75. Mele C, Iatropoulos P, Donadelli R et al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med 2011; 365: 295-306.
76. Kuźniar J, Kuźniar TJ, Marchewka Z et al. Elastase deposits in the kidney and urinary elastase excretion in patients with glomerulonephritis-evidence for neutrophil involvement in renal injury. Scand J Urol Nephrol 2007; 41: 527-534.
77. Boyer O, Nevo F, Plaisier E et al. INF2 mutations in charcot-marie-tooth disease with glomerulopathy. N Engl J Med 2011; 365: 2377-2388.
78. Roesli C, Fugmann T, Borgia B et al. Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy. Kidney Int 2011; 80: 272-281.
79. Krendel M, Kim SV, Willinger T et al. Disruption of myosin 1e promotes podocyte injury. J Am Soc Nephrol 2009; 20: 86-94.
80. Sanna-Cherchi S, Burgess KE, Nees SN et al. Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. Kidney Int 2011; 80: 389-396.
81. Kain R, Exner M, Brandes R et al. Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008; 14: 1088-1096.
82. Kawakami T, Takeuchi S, Arimura Y et al. Elevated antilysosomalassociated membrane protein-2 antibody levels in patients with adult Henoch-Schonlein purpura. Br J Dermatol 2012; 166: 1206-1212.
83. Kobayashi T, Notoya M, Shinosaki T et al. Cortactin interacts with podocalyxin and mediates morphological change of podocytes through its phosphorylation. Nephron Exp Nephrol 2009; 113: e89-e96.
84. Huang T-H, Shui H-A, Ka S-M et al. Rab 23 is expressed in the glomerulus and plays a role in the development of focal segmental glomerulosclerosis. Nephrol Dialysis Transplant 2009; 24: 743-754.
85. Fugmann T, Borgia B, Revesz C et al. Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy. Kidney Int 2011; 80: 272-281.
86. Hugo C, Nangaku M, Shankland SJ et al. The plasma membrane-actin linking protein, ezrin, is a glomerular epithelial cell marker in glomerulogenesis, in the adult kidney and in glomerular injury. Kidney Int 1998; 54: 1934-1944.
87. Saburi S, Hester I, Fischer E et al. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease. Nat Genet 2008; 40: 1010-1015.
88. Turnberg D, Botto M, Warren J et al. CD59a deficiency exacerbates accelerated nephrotoxic nephritis in mice. J Am Soc Nephrol 2003; 14: 2271-2279.
89. Praekelt U, Kopp PM, Rehm K et al. New isoform-specific monoclonal antibodies reveal different sub-cellular localisations for talin1 and talin2. Eur J Cell Biol 2012; 91: 180-191.
90. Fialka I, Steinlein P, Ahorn H et al. Identification of syntenin as a protein of the apical early endocytic compartment in Madin-Darby canine kidney cells. J Biol Chem 1999; 274: 26233-26239.
91. Westwood BM, Chappell MC. Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney. Peptides 2012; 35: 190-195.
92. Debiec H, Guigonis V, Mougenot B et al. Brief report-antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 2053-2060.
93. Takeda T. Podocyte cytoskeleton is connected to the integral membrane protein podocalyxin through Naþ/Hþ-exchanger regulatory factor 2 and ezrin. Clin Exp Nephrol 2003; 7: 260-269.
94. Tipnis SR, Hooper NM, Hyde R et al. A human homolog of angiotensinconverting enzyme: cloning and functional expression as a captoprilinsensitive carboxypeptidase. J Biol Chem 2000; 275: 33238-33243.
95. Ye M, Wysocki J, William J et al. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006; 17: 3067-3075.
96. Oberg AL, Vitek O. Statistical design of quantitative mass spectrometrybased proteomic experiments. J Proteome Res 2009; 8: 2144-2156.